Therefore, HOTAIR is proposed as a suitable therapeutic target for UA nephropathy, providing a novel theoretical basis for developing new drugs and correcting endothelial dysfunction in a HUA environment. This evidence concerns the gene HOTAIR and endothelial dysfunction.